Mozambique vs North Macedonia: Previously treated cases tested for RR-/MDR-TB
Mozambique
25.0%
in 2024
North Macedonia
29.0%
in 2024
Mozambique rank
164th
North Macedonia rank
161st
Previously treated cases tested for RR-/MDR-TB over time
- Mozambique
- North Macedonia
How they compare
North Macedonia currently reports 29.0% against 25.0% in Mozambique, a difference of 4.0%.
That makes North Macedonia's figure about 1.2 times Mozambique's.
The two have swapped places 2 times across 20 shared years of data; in 2005 it was North Macedonia ahead.
Mozambique ranks 164th and North Macedonia ranks 161st of 180 countries.
North Macedonia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Mozambique | North Macedonia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 12.8% | 33.2% | 20.4% | North Macedonia |
| 2010s | 30.4% | 71.8% | 41.4% | North Macedonia |
| 2020s | 72.4% | 77.4% | 5.0% | North Macedonia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Mozambique or North Macedonia?
- North Macedonia, at 29.0% against 25.0% in Mozambique as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Mozambique and North Macedonia?
- 4.0%, with North Macedonia ahead.
- How many years of comparable data are there for Mozambique and North Macedonia?
- 20 years are reported by both, from 2005 to 2024.
- How do Mozambique and North Macedonia rank globally for previously treated cases tested for rr-/mdr-tb?
- Mozambique ranks 164th and North Macedonia ranks 161st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.